{
    "eid": "2-s2.0-85023641125",
    "title": "The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study",
    "cover-date": "2017-12-01",
    "subject-areas": [
        {
            "$": "Gastroenterology",
            "@code": "2715"
        }
    ],
    "keywords": [
        "Meta-analysis",
        "Mortality",
        "Nonalcoholic fatty liver disease",
        "Nonalcoholic fatty liver disease fibrosis score",
        "Prognosis"
    ],
    "authors": [
        "Veeravich Jaruvongvanich"
    ],
    "citedby-count": 23,
    "ref-count": 26,
    "ref-list": [
        "Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes",
        "Medical progress: Nonalcoholic fatty liver disease",
        "Nonalcoholic fatty liver disease a systematic review",
        "Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity",
        "Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease",
        "Long-term follow-up of patients with NAFLD and elevated liver enzymes",
        "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease",
        "Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up",
        "Sampling variability of liver biopsy in nonalcoholic fatty liver disease",
        "Nonalcoholic fatty liver disease: Assessment of variability in pathologic interpretations",
        "Percutaneous ultrasonographically guided liver punctures: An analysis of 1961 patients over a period of ten years",
        "Noninvasive diagnosis of NASH and liver fibrosis within the spectrum of NAFLD",
        "The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD",
        "The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association",
        "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses",
        "Meta-analysis in clinical trials",
        "Measuring inconsistency in meta-analyses",
        "Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis",
        "Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease",
        "Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD",
        "Prognostic value of non-invasive fibrosis and steatosis tools, hepatic venous pressure gradient (HVPG) and histology in nonalcoholic steatohepatitis",
        "Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States",
        "NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients",
        "Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease",
        "Treatment of patients with cirrhosis",
        "Radiologic evaluation of nonalcoholic fatty liver disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "affilname": "Vagelos College of Physicians and Surgeons",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Honolulu",
            "affilname": "John A. Burns School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}